These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21710214)

  • 1. Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.
    Sheth AN; Patel P; Peters PJ
    Curr HIV/AIDS Rep; 2011 Sep; 8(3):181-91. PubMed ID: 21710214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
    Soonawala D; Rimmelzwaan GF; Gelinck LB; Visser LG; Kroon FP
    PLoS One; 2011 Jan; 6(1):e16496. PubMed ID: 21304982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.
    Weinberg A; Muresan P; Richardson KM; Fenton T; Dominguez T; Bloom A; Watts DH; Abzug MJ; Nachman SA; Levin MJ;
    PLoS One; 2015; 10(4):e0122431. PubMed ID: 25874544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Niño D; Wells JM; Arden N; Cheung S; Belmont JW
    Clin Infect Dis; 2012 Feb; 54(3):311-7. PubMed ID: 22075792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
    Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
    BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.
    Hellenbrand W; Jorgensen P; Schweiger B; Falkenhorst G; Nachtnebel M; Greutélaers B; Traeder C; Wichmann O
    BMC Infect Dis; 2012 May; 12():127. PubMed ID: 22650369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.
    Abzug MJ; Nachman SA; Muresan P; Handelsman E; Watts DH; Fenton T; Heckman B; Petzold E; Weinberg A; Levin MJ;
    Clin Infect Dis; 2013 May; 56(10):1488-97. PubMed ID: 23378284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
    Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
    Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of pandemic H1N1 2009 influenza vaccine for HIV-1 patients.
    Jilich D; Havlíčková M; Veselý D; Rozsypal H; Jiřincová H; Staňková M; Kynčl J; Malý M; Machala L
    Acta Virol; 2012; 56(4):349-51. PubMed ID: 23237093
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial.
    Viganò A; Giacomet V; Pariani E; Giani E; Manfredini V; Bedogni G; Erba P; Amendola A; Zanetti A; Zuccotti G
    Clin Vaccine Immunol; 2011 Sep; 18(9):1503-9. PubMed ID: 21795458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1)--United States, spring and summer 2009.
    Peters PJ; Skarbinski J; Louie JK; Jain S; ; Roland M; Jani SG; Finelli L; Brooks JT
    Clin Infect Dis; 2011 Jan; 52 Suppl 1():S183-8. PubMed ID: 21342893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High effectiveness of pandemic influenza A (H1N1) vaccination in healthcare workers from a Portuguese hospital.
    Costa JT; Silva R; Tavares M; Nienhaus A
    Int Arch Occup Environ Health; 2012 Oct; 85(7):747-52. PubMed ID: 22045387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada.
    Janjua NZ; Skowronski DM; Hottes TS; Osei W; Adams E; Petric M; Sabaiduc S; Chan T; Mak A; Lem M; Tang P; Patrick DM; De Serres G; Bowering D
    Clin Infect Dis; 2010 Nov; 51(9):1017-27. PubMed ID: 20887210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals.
    Kok J; Tudo K; Blyth CC; Foo H; Hueston L; Dwyer DE
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):91-4. PubMed ID: 21084991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity.
    Cooper CL
    Curr Opin Infect Dis; 2012 Feb; 25(1):26-35. PubMed ID: 22183114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children.
    Feiterna-Sperling C; Edelmann A; Nickel R; Magdorf K; Bergmann F; Rautenberg P; Schweiger B; Wahn V; Krüger DH; Hofmann J
    Clin Infect Dis; 2010 Dec; 51(11):e90-4. PubMed ID: 21039216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective cohort study comparing seasonal and H1N1(2009) pandemic influenza virus illnesses in HIV-infected children during 2009.
    Madhi SA; Kuwanda L; Venter M; Violari A
    Pediatr Infect Dis J; 2014 Feb; 33(2):174-6. PubMed ID: 23907261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.